Skip to content

The effects of Grape Seed Extract in adolescents with Metabolic Syndrome

The effects of Grape Seed Extract supplementation on insulin resistance , the serum biochemical markers, adiponectin and resistin in adolescents with metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013112611288N7
Enrollment
44
Registered
2016-02-04
Start date
2016-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Hyperglycaemia, unspecified

Interventions

Intervention 1: Intervention group : Grape Seed Extract capsules 100 mg once daily for 8 weeks. Intervention 2: daily supplementation with placebo capsules for 8 weeks.
Treatment - Drugs
Placebo
Intervention group : Grape Seed Extract capsules 100 mg once daily for 8 weeks
daily supplementation with placebo capsules for 8 weeks

Sponsors

Nutrition Research Center,Tabriz University of Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Adolescents aged 13-19 years;waist circumference (WC) above the 90th percentile in adolescents under 16 years old and WC more than 95 centimeter in adolescents over 16 years old plus 2 or more of the following items; HDL<40 mg/dL ( In teenage girls over 16 years old:HDL<50 mg/dL ) ; TG = 150mg/dL; Fasting blood glucose = 100 mg/dL; Systolic blood pressure = 130 mmHg; Diastolic blood pressure = 85mmHg Exclusion criteria: Suffering from heart disease ; Kidney disease ; Liver disease ; Hyperthyroidism or hypothyroidism; The use of anti-inflammatory drugs; smoking; Triglycerides above 500 mg per deciliter; Pregnancy in teenage girls ; The use of antioxidant supplements in the past three months; The use anticoagulant drugs , including aspirin , warfarin; Sensitivity to grapes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lipid profile (LDL, HDL, TG). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Enzymatic methods and Friedewald formula.;Fasting Blood Glucose. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Measurement of fasting blood glucose by using kits.;HbA1c. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Using ion exchange chromatography.;Fasting Plasma Insulin. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Elisa.;Anthropometric Indices (weight , height, waist circumference , BMI). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Using stadiometer, scale and tape.;Blood Pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Mercury sphygmomanometer.

Secondary

MeasureTime frame
Adiponectin. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Elisa kits.;Resistin. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Elisa kits.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 24, 2026